$1.26
-0.01-0.79%
Last update: Nov 11, 6:03 PM
BioVie Inc
BIVINASDAQ
BioVie fell 16.6% from $1.51 to $1.26, behind the S&P 500's +11.2%. Its worst day was Aug 6 (−33.8%), and its low came Aug 18 at $0.96.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.77 beat the $-0.81 estimate on $0.00 revenue.
+2.7% · S&P 500 +0.5%
EPS of $-0.70 beat the $-0.73 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
−2.2% · S&P 500 −0.2%
BioVie shares fell 27.8%, while the S&P 500 fell 0.8%.
−27.8% · S&P 500 −0.8%
EPS of $-0.70 was reported on $0.00 revenue.
0.0% · S&P 500 +0.7%
BioVie closed at its highest level of the year, 51.0% above where the year started.
+5.6% · S&P 500 −0.3%
EPS of $-0.68 was reported on $0.00 revenue.
−2.3% · S&P 500 +2.4%
Where it ended: a close of $1.26 on Nov 11, 2026. Up next: Q2 2027 earnings on Feb 5, 2027.
Nothing in the past 12 months.
All BIVI analyst actionsNothing in the past 12 months.
All BIVI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BIVI and SPY from Benzinga historical bars. Not investment advice.
